Identification of Objective Metabolomics-based Biomarkers of Yogurt Consumption
NCT07491887 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2026-04-02
Summary
Substantial evidence links yogurt consumption to a lower risk of type 2 diabetes (T2D). However, the existing evidence is derived exclusively from prospective cohort studies relying on self-reported dietary questionnaires, which-despite being validated-are subject to random and systematic errors that may compromise evidence quality and hinder regulatory approval.
The project aims to discover and validate biomarkers of yogurt intake.
The investigators will conduct a randomized, crossover, dose-response feeding trial involving 16 generally healthy adult participants (8 females, 8 males). The trial will include four 7-day diet periods, each separated by a 1-week washout. All diets will be based on a dairy-free background and supplemented with one of the following: (a) 1 serving of soy-based pudding (no yogurt), (b) 0.5 serving of yogurt, (c) 1 serving of yogurt, or (d) 2 servings of yogurt per 2,380 kcal/day.
On the 7th day of each diet, participants will complete a mixed-meal test at INAF, consuming a smoothie containing the same yogurt dose as during the preceding days. Plasma samples collected in the postprandial state will be used to profile over 20,000 metabolites. Using artificial intelligence-based approaches, potential biomarkers of yogurt intake will be identified. These candidates will then be filtered using standard statistical methods to assess dose- and time-responsiveness, robustness, and biological plausibility. Biomarkers that meet all criteria will be considered validated indicators of yogurt intake.
Conditions
- Diet
Interventions
- OTHER
-
Yogurt-free diet
During 6 days, participants will receive a fully-controlled dairy-free background diet reflecting high adherence to Canada's food guide. The diet will be complemented by 125 g per 2,380 kcal per day of a soy-based pudding. On day 7, participants will undergo an acute mixed-meal test to inform on time-responsiveness of the yogurt biomarkers. After a 12-hour fast, participants will arrive at INAF at 7:30 AM. The test meal will consist of a breakfast smoothie containing the same soy-based pudding provided daily during the preceding days. Plasma samples will be collected at baseline (fasting) and 1, 2, 4, and 6 hours post-meal.
- OTHER
-
Low-yogurt diet
During 6 days, participants will receive a fully-controlled dairy-free background diet reflecting high adherence to Canada's food guide. The diet will be complemented by 90 g per 2,380 kcal per day of yogurt (i.e., 0.5 reference serving of yogurt per 2,380 kcal per day). On day 7, participants will undergo an acute mixed-meal test to inform on time-responsiveness of the yogurt biomarkers. After a 12-hour fast, participants will arrive at INAF at 7:30 AM. The test meal will consist of a breakfast smoothie containing the same yogurt provided daily during the preceding days. Plasma samples will be collected at baseline (fasting) and 1, 2, 4, and 6 hours post-meal.
- OTHER
-
Moderate-yogurt diet
During 6 days, participants will receive a fully-controlled dairy-free background diet reflecting high adherence to Canada's food guide. The diet will be complemented by 175 g per 2,380 kcal per day of yogurt (i.e., 1 reference serving of yogurt per 2,380 kcal per day). On day 7, participants will undergo an acute mixed-meal test to inform on time-responsiveness of the yogurt biomarkers. After a 12-hour fast, participants will arrive at INAF at 7:30 AM. The test meal will consist of a breakfast smoothie containing the same yogurt provided daily during the preceding days. Plasma samples will be collected at baseline (fasting) and 1, 2, 4, and 6 hours post-meal.
- OTHER
-
High-yogurt diet
During 6 days, participants will receive a fully-controlled dairy-free background diet reflecting high adherence to Canada's food guide. The diet will be complemented by 350 g per 2,380 kcal per day of yogurt (i.e., 2 reference servings per 2,380 kcal per day). On day 7, participants will undergo an acute mixed-meal test to inform on time-responsiveness of the yogurt biomarkers. After a 12-hour fast, participants will arrive at INAF at 7:30 AM. The test meal will consist of a breakfast smoothie containing the same yogurt provided daily during the preceding days. Plasma samples will be collected at baseline (fasting) and 1, 2, 4, and 6 hours post-meal.
Sponsors & Collaborators
-
Laval University
lead OTHER
Principal Investigators
-
Jean-Philippe Drouin-Chartier, PhD · Laval University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-23
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- Canada
Study Locations
More Related Trials
-
The Effect of Dairy and Non-dairy Breakfasts on Satiety and Post-meal Glycemia in Healthy Older Adults
NCT02607007 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metabolic Signatures of Dairy Products Ingestion in Humans: Effect of Age
NCT03500003 ·Status: COMPLETED ·Phase: NA
-
Dairy Fat and Fermentation Study
NCT05840081 ·Status: COMPLETED ·Phase: NA
-
Impact of Dairy Integration Into Canadian Food Guide on Gut Health
NCT07257913 ·Status: RECRUITING ·Phase: NA
-
Impact of Yogurt on Gastrointestinal Health, Regularity, and Thoughts
NCT04901390 ·Status: COMPLETED ·Phase: NA
-
Improving Health Outcomes With Kefir
NCT06695221 ·Status: RECRUITING ·Phase: NA
-
Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt
NCT01686204 ·Status: COMPLETED ·Phase: NA
-
Effect of Nutritional Interventions on Inflammatory Status in Healthy Overweight Men
NCT00655798 ·Status: COMPLETED ·Phase: NA
-
Effect of a Drinkable Yogurt Enriched in Proteins and Fibers on Satiety
NCT01304004 ·Status: COMPLETED ·Phase: NA
-
Dairy and Vegan Cheese: Effect on Satiety and Blood Glucose
NCT06568497 ·Status: RECRUITING ·Phase: NA
-
Ultra-processed Food Consumption, Gut Microbiota, and Glucose Homeostasis
NCT05358171 ·Status: COMPLETED ·Phase: NA
-
Effect of Pre-meal Serving of Dairy and Dairy Alternatives on Post-meal Satiety and Glycaemia in Healthy Young Adults
NCT04600128 ·Status: COMPLETED ·Phase: NA
-
A Trial to Assess Full-fat or Low-fat Dairy Foods on Insulin Sensitivity, RBC FA's and Other Markers of Metabolic Health
NCT04999462 ·Status: COMPLETED ·Phase: NA
-
Effect of High Cheese Consumption on Metabolic Syndrome Risk Factors
NCT02616471 ·Status: COMPLETED ·Phase: NA
-
The Impact of Consumption of Eggs in the Context of Plant-Based Diets on Endothelial Function, Diet Quality, and Cardio-Metabolic Risk Factors in Adults at Risk for Type 2 Diabetes
NCT04316429 ·Status: COMPLETED ·Phase: NA
-
Study of the Impact of Low Fat Dairy and High Fat Dairy Consumption on Daytime Ambulatory Blood Pressure
NCT02763930 ·Status: COMPLETED ·Phase: NA
-
Kefir Cholesterol Lowering Pilot Study
NCT04247139 ·Status: COMPLETED ·Phase: NA
-
Dairy and Inflammation Study
NCT04902417 ·Status: COMPLETED ·Phase: NA
-
Effect of the Consumption of a Fermented Dairy Drink on the Immune Function
NCT01521182 ·Status: COMPLETED ·Phase: NA
-
Investigation of Microbiome-Derived Metabolite Production in Response to a Mediterranean Diet
NCT03783260 ·Status: COMPLETED ·Phase: NA
-
Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome
NCT02656056 ·Status: COMPLETED ·Phase: PHASE1
-
Functional Yogurt Consumption and Its Effects on the Lipid Profile of Healthy Subjects
NCT06574711 ·Status: COMPLETED ·Phase: NA
-
A Study Of Milk Consumption In Metabolic Syndrome
NCT07401888 ·Status: RECRUITING ·Phase: NA
-
Fermented Dairy Products and The Metabolic Syndrome
NCT04755530 ·Status: COMPLETED ·Phase: NA
-
Assessment of Dietary Biomarkers and Metabolic Effects After the Intake of Milk and Cheese
NCT02705560 ·Status: UNKNOWN ·Phase: NA